Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Turin
Clinical trial register · Italy

Clinical Trials in Turin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie13 Hoffmann-La Roche12 Sanofi9 Merck Sharp & Dohme LLC8 University of Turin, Italy7
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Turin

153 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Neonatal Catheter Lock for Infection Prevention
NCT07585188CLABSI - Central Line Associated Bloodstream Infection, CRBSI - Catheter Related Bloodstream Infection, Neonatal Sepsis, Late-Onset
University of Turin, Italy
Not applicable
576
Turin
2026-10
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Bari, Bologna, Matera, Negrar, Rome, Rozzano, San Giovanni Rotondo, Turin
2026-08-28
Recruiting
Liaquat University of Medical & Health Sciences
Not applicable
132
Forlì, Ravenna, Rome, Brescia, Pavia, Turin, Catania, Florence
2026-03-23
Recruiting
Santen SAS
Observational
112
Rome, Turin
2026-03-19
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Naples, Turin, Padova, Milan, Roma
2026-03-13
Recruiting
Proed, Torino, Italy
Observational
24
Turin
2026-01-27
By invitation
Biotics Intervention Oriented to Rescue From Environmental Pollution Inflammatory Responses
NCT07418489Healthy 70 Street Market Vendors Working in Highly-polluted Areas of Turin
University of Turin, Italy
Not applicable
70
Turin
2026-01-24
Recruiting
Sanofi
Phase 3
751
Rozzano, Turin
2026-01-22
Recruiting
Sanofi
Phase 2
37
Rome, Turin, Monza
2025-12-02
Recruiting
SAb Biotherapeutics, Inc.
Phase 2
159
Milan, Turin, Verona
2025-11-25
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Turin
2025-11-23
Recruiting
Brief Clinical Psychological Intervention With Biofeedback in Head and Neck Cancer
NCT07712120Head and Neck Cancer, Surgery for Head and Neck Cancer Patients, Demolitive Surgical Procedures on the Oral Cavity or Oropharynx, With or Without Simultaneous Reconstruction Using Flaps
University of Turin, Italy
Not applicable
58
Turin
2025-11-20
Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Bologna, Milan, Rome, Turin
2025-11-19
Recruiting
Sanofi
Phase 2
54
Milan, Padua, Rome, Turin
2025-10-14
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsRuxolitinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsDasatinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Recruiting
Sanofi
Phase 3
980
Rome, Rozzano, Turin
2025-10-01
Recruiting
Genentech, Inc.
Phase 2
224
Rome, Brescia, Milan, Rho, Rozzano, San Donato Milanese (MI), Turin, Negrar
2025-09-29
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Sanofi
Phase 3
723
Florence, Genoa, Milan, Rome, Turin, Bologna, Messina, Novara
2025-08-06
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Florence, Genoa, Milan, Padua, Turin, Udine, Varese
2025-07-25
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
DrugsUplizna·Inebilizumab·Blinatumomab
Amgen
Phase 2
220
Milan, Rozzano, Turin
2025-07-16
Recruiting
AbbVie
Observational
250
Castellana Grotte, Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Naples, Turin
2025-07-14
Recruiting
AbbVie
Observational
270
Troina, Pozzilli, Milan, Naples, Turin, Rome, Venice, Ancona
2025-06-04
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Castellana Grotte, Pavia, Legnano, Rozzano, San Donato Milanese, Segrate, Turin, Bologna
2025-05-27
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Catania, Padua, Salerno, Turin
2025-05-21
Recruiting
Takeda
Phase 3
225
Ancona, Turin, Florence, Milan, Pavia, Reggio Calabria, Rome, Rozzano
2025-05-06
Recruiting
The FOCUS-ADHF Registry
NCT06726109Acute Heart Failure With Reduced Ejection Fraction, Decompensation; Heart, Congestive, Regurgitation, Mitral
ASL Città di Torino
Observational
600
Rivoli, Turin, Udine
2025-04-27
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT06965023ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
Azienda Ospedaliera "Sant'Andrea"
Observational
130
Roma, Caserta, Catania, Ferrara, Forlì, Milan, Naples, Turin
2025-04-22
Not yet open
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
NCT06907563Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Steatotic Liver Disease of Mixed Origin (MetALD), ALD - Alcoholic Liver Disease
Universität des Saarlandes
Observational
30,000
Turin
2025-04-15
Active, closed
Sanofi
Phase 2
204
Genoa, Milan, Rozzano, Naples, Padua, Rome, Turin, Alessandria
2025-03-28
Recruiting
AbbVie
Observational
700
Milan, Naples, Turin, Rome, Bari, Palermo
2025-03-28
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Milan, Rozzano, Turin, Bologna, Genova, Udine
2025-03-12
Recruiting
Amgen
Phase 3
844
Udine, Rome, Milan, Turin, Verona, Pisa, Reggio Emilia
2025-02-25
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2025-02-11
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Rozzano, Padua, Turin
2025-01-22
Recruiting
Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms
NCT07033741Depression, Anxiety, Post-traumatic Stress Symptoms, Dissociation, Psychotherapy Research and Outcome Measures
University of Turin, Italy
Observational
40
Turin
2025-01-08
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Abbott Medical Devices
Not applicable
850
Turin
2024-12-13
Active, closed
Vicore Pharma AB
Phase 2
378
Ancona, Bergamo, Monza, Roma, Turin
2024-12-09
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Bologna, Padova, Florence, Catania, Milan, Turin
2024-11-15
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
NCT06884358Anderson-Fabry Disease
IRCCS Policlinico S. Donato
Observational
100
Brescia, Milan, San Donato Milanese, Monza, Turin
2024-11-13
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
104
Naples, Parma, Pisa, Rome, Turin
2024-10-25
Recruiting
University of Turin, Italy
Not applicable
20
Turin
2024-09-12
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2024-08-31
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
San Donato Milanese, Turin, Pisa
2024-08-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Rome, Milan, Turin, Catania
2024-08-05
Recruiting
Dr. Inge Winter
Phase 4
418
Brescia, Cagliari, Naples, Turin
2024-08-01
Recruiting
A.O.U. Città della Salute e della Scienza
Observational
177
Turin
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bologna, Milan, Monza, Rozzano, Turin, Brescia, Catania, Naples
2024-07-24
Recruiting
A.O.U. Città della Salute e della Scienza
Observational
50
Turin
2024-07-10
Recruiting
University of Bologna
Observational
120
Bologna, Catania, Milan, Padova, Palermo, Rome, Siena, Turin
2024-07-09
Recruiting
European Foundation for Study of Chronic Liver Failure
Phase 2
90
Bologna, Turin
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Chieti, Caserta, Cona (Ferrara), Latina, Bergamo, San Donato Milanese, Turin, Pordenone
2024-06-25
Recruiting
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
NCT06099015Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation, Portal Hypertension
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
132
Milan, Turin, Varese
2024-06-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Active, closed
Windtree Therapeutics
Phase 1/2
20
Alessandria, Brescia, Milan, Turin
2024-06-01
Active, closed
AbbVie
Phase 3
421
Legnano, Turin, Rome, Ancona, Catania
2024-05-19
Active, closed
Sanofi
Phase 3
464
Turin, Chieti, Modena, Naples, Perugia
2024-02-29
Recruiting
Terumo Europe N.V.
Not applicable
50
Milan, Rome, Turin
2024-02-27
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
Pfizer
Phase 3
492
Milan, Legnano, Turin, Palermo, Ancona, Florence, Pisa, Bologna
2024-02-08
Recruiting
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046GVHD - Graft-Versus-Host Disease, Infections After HSCT, Transplant Associated Microangiopathy TAM, Sinusoidal Obstruction Syndrome (SOS)
University of Turin, Italy
Observational
30
Milan, Turin
2024-01-31
Active, closed
Sanofi
Phase 3
260
Torette, Genoa, Milan, Rozzano, Rome, Turin, Bergamo, Bologna
2024-01-23
Recruiting
Pragmatic Optimized Rifampicin Trial
NCT06057519Tuberculosis, Pulmonary
Radboud University Medical Center
Phase 3
164
Turin
2024-01-16
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Active, closed
AOP Orphan Pharmaceuticals AG
Phase 3
117
Bologna, Florence, Rome, Turin
2023-12-04
Recruiting
Remote ECG Monitoring Post TAVI
NCT07521800TAVI(Transcatheter Aortic Valve Implantation), Remote Monitoring, Arrythmia, Atrial Fibrillation (AF)
Medical University of Silesia
Not applicable
250
Turin
2023-12-01
Recruiting
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT06158698Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure
DrugColchicine
Niguarda Hospital
Phase 3
80
Naples, Bologna, Trieste, Udine, Rome, Milan, Turin, Ancona
2023-11-14
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsTrametinib·Cytarabine·Dexamethasone·Cyclophosphamide
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
medac GmbH
Phase 2
49
Bologna, Monza, Pavia, Rome, Turin
2023-11-13
Active, closed
Bristol-Myers Squibb
Phase 3
402
Rome, Milan, Rozzano, Turin, Florence, Bologna, Reggio Calabria, Roma
2023-10-24
Recruiting
Hoffmann-La Roche
Phase 3
182
Bologna, Bergamo, Milan, Alessandria, Turin
2023-10-22
Recruiting
W.L.Gore & Associates
Not applicable
244
Milan, Perugia, Roma, Turin
2023-10-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Recruiting
A.O.U. Città della Salute e della Scienza
Not applicable
50
Torino, Turin
2023-10-01
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Recruiting
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
NCT05689619Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer
A.O.U. Città della Salute e della Scienza
Not applicable
70
Genova, Messina, Rome, Turin
2023-09-01
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Rome, Genoa, Pavia, Turin
2023-08-08
Active, closed
AstraZeneca
Phase 3
111
Milan, Naples, Padova, Pisa, Rozzano, Turin
2023-06-27
Active, closed
AbbVie
Phase 1
135
Milan, Turin, Bergamo, Bologna
2023-06-09
Recruiting
Hoffmann-La Roche
Phase 3
420
Caserta, Meldola, Ravenna, Aviano, Milan, Alessandria, Turin, Misterbianco (CT)
2023-06-07
Not yet open
Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation
NCT05782738Coronary Artery Disease, Coronary Stenosis, Coronary Disease
San Luigi Gonzaga Hospital
Not applicable
361
Cirié, Moncalieri, Alessandria, Cuneo, Turin
2023-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Genoa, Milan, Turin, Rome, Florence, Padova
2023-05-31
Active, closed
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
NCT05639569Aneurysm Thoracic, Dissection of Thoracic Aorta
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
147
Turin
2023-05-03
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Bologna, Milan, Palermo, Pisa, Reggio Emilia, Roma, Siena, Turin
2023-03-29
Active, closed
Hoffmann-La Roche
Phase 3
85
Genoa, Turin
2023-03-29
Recruiting
Spanish Oncology Genito-Urinary Group
Phase 2
90
Milan, Turi, Turin
2023-03-07
Active, closed
AstraZeneca
Observational
551
Naples, Cona, Udine, Rome, Brescia, Milan, Turin, Cagliari
2023-02-27
Recruiting
Tampere University
Not applicable
12,000
Genova, Milan, Rome, Turin
2023-02-01
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Bologna, Rome, Milan, Rozzano, Turin, Padova
2023-01-23
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Turin, Brescia, Florence, Milan, Verona
2023-01-09
Recruiting
Montreal Heart Institute
Phase 3
10,000
Foggia, Acquaviva delle Fonti, Ferrara, Ravenna, Milan, Turin, Ancona, Florence
2022-12-21
Recruiting
Hoffmann-La Roche
Phase 1/2
65
Rome, Turin
2022-11-16
Recruiting
Pfizer
Phase 3
1,060
Meldola (Fc), Piacenza, Ravenna, San Giovanni Rotondo, Aviano, Monza, Turin, Palermo
2022-11-10
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
87
Milan, Pavia, Rozzano, Turin, Roma
2022-11-07
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Bologna, Bergamo, Milan, Turin
2022-10-17
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Recruiting
Study of the Role of Genetic Modifiers in Hemoglobinopathies
NCT05799118Sickle Cell Disease, Thalassemia, Beta, Thalassemia Alpha, Hemoglobinopathies
Cyprus Institute of Neurology and Genetics
Observational
30,000
Turin
2022-10-01
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Recruiting
Acrivon Therapeutics
Phase 2
350
Aviano, Catania, Milan, Naples, Pieve Emanuele, Roma, Turin
2022-08-29
Active, closed
Sanofi
Phase 2/3
1,856
Milan, Rozzano, Naples, Rome, Turin, Bologna, Catania, Chieti
2022-08-22
Active, closed
Regeneron Pharmaceuticals
Phase 3
202
Florence, Rome, Turin
2022-08-01
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Turin, Florence, Genova, Milan, Pavia, Reggio Emilia, Roma
2022-03-29
Recruiting
AbbVie
Phase 2
75
Turin, Terni
2022-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Naples, Bologna, Meldola, Milan, Turin, Rome, Florence, Vicenza
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Bologna, Milan, Monza, Turin, Brescia
2021-12-13
Active, closed
AbbVie
Observational
873
Bari, Catania, Genoa, Messina, Milan, Turin, Roma, Cava de' Tirreni
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Genoa, Milan, Turin
2021-09-14
Recruiting
Italian Treatment Free Remission Registry
NCT04769947Treatment Free Remission, Chronic Myeloid Leukemia
University of Turin, Italy
Observational
800
Turin
2021-08-09
Active, closed
VectivBio AG
Phase 3
158
Bologna, Rome, Turin
2021-07-13
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Bologna, Genova, Milan, Perugia, Turin, Verona
2021-05-21
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Recruiting
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
NCT04761120Mitral Regurgitation, Tricuspid Regurgitation, Valvular Heart Disease
Abbott Medical Devices
Observational
550
Bologna, Milan, Turin
2021-02-01
Active, closed
Hoffmann-La Roche
Phase 2
920
Rome, Brescia, Milan, Turin, Siena
2021-01-18
Active, closed
Hoffmann-La Roche
Phase 3
769
Naples, Rome, Gallarate, Milan, Pavia, Turin
2020-12-03
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Bologna, Catania, Milan, Tortona, Turin
2020-11-04
Active, closed
Bayer
Phase 3
402
Naples, Parma, Orbassano, Turin, Padova
2020-10-20
Active, closed
Hoffmann-La Roche
Phase 3
190
Ravenna, Rome, Milan, Turin, Florence
2020-09-30
Active, closed
University of Zurich
Not applicable
986
Cuneo, Genova, Palermo, Turin
2020-09-30
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Active, closed
Prospective and Non-randomized Registry of CardioCel 3D
NCT04175327Intracardiac and Septal Defects, Valve and Anulus Repair, Great Vessel Reconstruction, Peripheral Vessel Reconstruction
LeMaitre Vascular
Observational
200
San Donato Milanese, Turin
2020-08-28
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Bologna, Milan, Roma, Turin
2020-06-12
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Naples, Rome, Milan, Turin, Pisa, Siena, Padova, Catania
2020-02-11
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Turin, Bologna, Padua, Roma, Rozzano
2020-01-05
Active, closed
Pfizer
Phase 3
1,068
Misterobianco (CT), Cremona, Rozzano, Turin, Reggio Emilia, Arezzo, Bari, Genova
2019-12-30
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Bari, Bolzano, Cagliari, Careggi, Catania, Modena, Siena, Turin
2019-12-17
Active, closed
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922Primary Glioblastoma, Glioblastoma Multiforme
DrugLAM561
Laminar Pharmaceuticals
Phase 2/3
144
Padova, Milan, Roma, Turin
2019-12-01
Active, closed
Surveillance AFter Extremity Tumor surgerY
NCT03944798Soft Tissue Sarcoma, Lung Metastases
McMaster University
Not applicable
310
Turin
2019-11-19
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
Tobias Feuchtinger
Phase 3
149
Rome, Turin
2019-08-27
By invitation
University of Edinburgh
Observational
287
Florence, Siena, Turin
2019-04-05
Recruiting
RECORDATI GROUP
Observational
95
Florence, Milan, Monza, Naples, Padova, Turin
2019-01-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Bergamo, Naples, Padova, Roma, Siena, Turin, Udine
2018-10-30
Active, closed
AbbVie
Phase 3
265
Bologna, Turin, Rionero in Vulture, Ancona, Milan, Palermo, Terni
2018-10-22
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Turin, Bergamo, Milan, Naples, Padova, Siena
2018-04-11
Active, closed
Bellicum Pharmaceuticals
Phase 1
15
Pavia, Rome, Turin
2018-02-01
Active, closed
Acerta Pharma BV
Phase 3
635
Bologna, Milan, Palermo, Parma, Pavia, Reggio Emilia, Rozzano, Turin
2017-04-05
Active, closed
Philogen S.p.A.
Phase 3
214
Genova, Milan, Padova, Naples, Siena, Trieste, Turin
2016-07-01
Active, closed
AbbVie
Phase 3
1,629
Rozzano, Turin, Milan, Verona
2015-12-01
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Ancona, Milan, Palermo, Rome, Turin
2015-05-01
Active, closed
Wuerzburg University Hospital
Observational
3,656
Turin
2015-01-01
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Active, closed
University of Miami
Not applicable
161
Turin
2013-04-04
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Aviano, Ravenna, Turin
1998-10
Rows per page Showing 1–153 of 153
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/turin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 153 of those studies with a site in Turin.

How many clinical trials are recruiting in Turin?

78 of the 153 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 69 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Turin), 153 studies
PhaseStudiesRecruitingShare
Phase 3612239.9%
Observational332321.6%
Not applicable201313.1%
Phase 2201213.1%
Phase 1/2845.2%
Phase 2/3734.6%
Phase 1201.3%
Phase 4211.3%

Most active sponsors

Lead sponsors with the most studies (Turin)
Lead sponsorStudiesRecruiting
AbbVie135
Hoffmann-La Roche123
Sanofi95
Merck Sharp & Dohme LLC82
University of Turin, Italy75
Regeneron Pharmaceuticals53
A.O.U. Città della Salute e della Scienza44
Bristol-Myers Squibb41
Abbott Medical Devices33
AstraZeneca31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.